谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Phase 1 Study Of Cb-839, A First-In-Class Oral Inhibitor Of Glutaminase, In Combination With Paclitaxel In Patients With Advanced Triple Negative Breast Cancer

Kevin Kalinsky,James J. Harding,Angela Demichele,Jeffrey R. Infante,Keerthi Gogineni,Taofeek K. Owonikoko,Steven Isakoff,Othon Iliopoulos,Manish R. Patel,Pamela Munster,Melinda L. Telli,Yonchu Jenkins,Gayle P. Fiji,Samuel H. Whiting,Funda Meric-Bernstam

CANCER RESEARCH（2018）

引用 5|浏览21
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要